Shares of Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) have been given an average rating of “Buy” by the seven brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation, five have issued a buy recommendation and one has given a strong buy recommendation to […]

View Entire Post